Discovery of biphenyl-based VEGFR-2 inhibitors. Part 3: Design, synthesis and 3D-QSAR studies

Add time:07/23/2019    Source:sciencedirect.com

VEGFR-2 plays an essential role in angiogenesis and is a central target for anticancer drug discovery. In order to develop novel VEGFR-2 inhibitors, we designed and synthesized 33 biphenyl amides based on our previously reported lead compound. The biological results indicated that four compounds (18b, 20e, 20h and 20j) are potent VEGFR-2 inhibitors which are comparable to positive control. Compound 18b displayed the most potent VEGFR-2 inhibition with IC50 value of 2.02 nM. Moreover, it exhibited promising antiproliferative activity against MCF-7 and SMMC-7721 cells with IC50 values of 1.47 μM and 5.98 μM, respectively. Molecular docking and 3D-QSAR studies were also carried out. The results indicated that these biphenyl amides could serve as promising leads for further optimization as novel VEGFR-2 inhibitors.

We also recommend Trading Suppliers and Manufacturers of 3-(2-MORPHOLIN-4-YLETHOXY)ANILINE (cas 112677-72-2). Pls Click Website Link as below: cas 112677-72-2 suppliers

Prev:Pronounced luminescence efficiency and thermal stability of small imidazole architect 2-(1, 4, 5-triphenyl-1H-imidazol-2-yl)phenol for efficient non-doped blue OLEDs
Next:Discovery of novel VEGFR-2 inhibitors. Part II: Biphenyl urea incorporated with salicylaldoxime)